These observations indicate that the deletion of the KCNQ1 region which contains that T2D risk haplotype affects beta-cell mass; therefore, it is possible that the T2D risk allele(s) decrease CDKN1C expression during the endocrine progenitor stage resulting in reduced pancreatic beta-cell mass. This evidence concerns the gene CDKN1C and type 2 diabetes mellitus.